FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: Multicentric study

E. Lopci, I. Santi, E. Derenzini, C. Fonti, G. Savelli, F. Bertagna, M. Bellò, B. Botto, D. Huglo, F. Morschhauser, P. Zinzani, S. Fanti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'FDG-PET in the assessment of patients with follicular lymphoma treated by ibritumomab tiuxetan Y 90: Multicentric study'. Together they form a unique fingerprint.

Medicine & Life Sciences